Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Hepatocellular × Oxaliplatin × Clear all

Phase

Phase 2 24 Phase 3 13 Phase 2/3 5 Phase 1 5 Phase NA 4 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 32 Pancreatic Neoplasms 25 Rectal Neoplasms 18 Stomach Neoplasms 16 Colonic Neoplasms 15 Esophageal Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 6 Neoplasm Metastasis 5 Gastrointestinal Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Liver Neoplasms 4 Adenocarcinoma Of Esophagus 4 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gallbladder Neoplasms 3 Cholangiocarcinoma 3 Biliary Tract Neoplasms 3 Advanced Solid Tumor 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Leukemia, Prolymphocytic 2 Leukemia 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Colorectal Cancer Metastatic 2 Bile Duct Neoplasms 2 Advanced Solid Tumors 2 Adenocarcinoma 2 Solid Cancer 1

Interventions

Sorafenib 24 Nivolumab 19 pembrolizumab 15 lenvatinib 11 Bevacizumab 9 Cyclophosphamide 8 Ipilimumab 7 atezolizumab 6 apatinib 5 Specimen Handling 5 tislelizumab 4 durvalumab 4 Radiosurgery 4 Immunotherapy, Adoptive 4 Doxorubicin 4 toripalimab 3 fludarabine 3 camrelizumab 3 X-Rays 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 Everolimus 3 Erlotinib Hydrochloride 3 tremelimumab 2 tepotinib 2 spartalizumab 2 sintilimab 2 sapanisertib 2 regorafenib 2 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06741020 2025-05-23

HAICI

Zhejiang Cancer Hospital

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡